Summary: Syringe-sharing behaviors among injection drug users (IDUs) are typically based on self-reports and subject to socially desirable responding. We used 3 short tandem repeat (STR) genetic biomarkers to detect sharing in 2512 syringes exchanged by 315 IDUs in the Baltimore needle exchange program (NEP; 738 personvisits). Demographic characteristics as well as direct and indirect needle-sharing behaviors corresponding to the closest AIDS Link to Intravenous Experience (ALIVE) study visits were examined for association with multiperson use (MPU) of syringes. Overall, 56% of the syringes exchanged at the Baltimore NEP had evidence of MPU. Less MPU of syringes (48% vs. 71%; P , 0.0001) was seen with more rapid syringe turnaround (,3 days). IDUs always exchanging their own syringes (''primary'' syringes) were less likely to return syringes with evidence of MPU (52%) than those who exchanged syringes for others (''secondary'' syringes; 64%; P = 0.0001) and those exchanging primary and secondary syringes (58%; P = 0.004). In a multivariate analysis restricted to primary exchangers, MPU of syringes was associated with sharing cotton (adjusted odds ratio [AOR] = 2.06, 95% confidence interval [CI]: 1.30 to 3.28), lending syringes (AOR = 1.70, 95% CI: 1.24 to 2.34), and injecting less than daily (AOR = 0.64, 95% CI: 0.43 to 0.95). These findings support additional public health interventions such as expanded syringe access to prevent HIV and other blood-borne infections. Testing of STRs represents a promising approach to examining and accessing complex behavioral data, including syringe sharing.
S
yringe sharing has been identified as a major risk factor for the acquisition of blood-borne pathogens among injection drug users (IDUs). [1] [2] [3] [4] [5] ''Direct'' sharing takes place when an individual passes on his or her used needle and/or syringes to another, exposing that second person to residual traces of the first person's biologic material. 6, 7 Likewise ''indirect'' sharing of syringes by means of ''backloading'' and ''frontloading'' 6, 8, 9 or sharing of injection paraphernalia such as cookers, cotton filters, and rinsing water 10, 11 can expose users to infectious agents, including HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV). 9, [12] [13] [14] [15] [16] Several studies have reported that the prevalence of injection paraphernalia sharing is 2 to 3 times greater than that of direct needle sharing. 13, 17, 18 Needle exchange programs (NEPs) have been deployed as a harm reduction strategy to prevent the acquisition of blood-borne infections among IDUs. 19, 20 A major objective of NEPs is to decrease the circulation of potentially contaminated multiperson-use (MPU) syringes in the community, thereby lowering the incidence of blood-borne infections. 21, 22 Several studies have shown that NEPs are associated with decreased needle sharing, 18, [23] [24] [25] [26] reductions in HIV prevalence, 27, 28 and reductions in HIV incidence. 29, 30 Almost all NEP evaluation studies have relied on selfreports of needle sharing among attendees. 31 Based on selfreports, needle-sharing behavior is high among IDUs attending NEPs at baseline 18, 23 but significantly declines over time among HIV-seronegative 2, 18, 23, 32, 33 and HIV-seropositive NEP attendees. 24, 34 Self-reported behaviors of IDUs are generally valid; 35 however, they may be prone to socially desirable responding. 36, 37 Recent studies using audio computer-assisted self-interview (ACASI) indicate that IDUs tend to underreport sensitive behaviors such as needle sharing during face-to-face interviews. 38, 39 Although self-reported data, if interpreted cautiously, can be used to study IDU behaviors, molecular assessment of DNA from used syringes promises to provide another level of certainty about risk behaviors. Obtaining valid biologic markers for MPU syringe analysis minimizes the potential biases and limitations of self-reports. Short tandem repeats (STRs) are a type of genetic marker for which theoretic and laboratory approaches have been previously developed for syringe residue analysis. 40, 41 Briefly, STRs are tandemly repeated simple DNA sequence motifs that are 2 to 7 bases in length. [42] [43] [44] STRs are characterized by Mendelian inheritance and are widely dispersed in the genome of all racial, ethnic, and geographically defined populations, [45] [46] [47] making them useful in forensic identification applications and genetic epidemiology. Allelic polymorphisms originate as mutations caused by slipped-strand mispairing during DNA replication. 48, 49 The variability results from the gain or loss of repeat units, with mutation rates typically ranging from 10 23 to 10 25 events per gamete per generation. 50, 51 Detecting 3 or more alleles at an STR in a single biologic sample provides evidence of biologic mixture from at least 2 individuals.
Improved documentation of syringe-sharing behaviors among IDUs could provide insights to preventing and controlling epidemics of HIV and other blood-borne infections. The purpose of this study was to study the extent of MPU of syringes returned to the Baltimore NEP based on genetic biomarkers (pentanucleotide STRs) 41 and to examine the association between MPU of syringes and self-reports of needle-sharing behavior in a retrospective study of NEP attendees.
METHODS

Study Samples
The study design and methods for the AIDS Link to Intravenous Experience (ALIVE) study have been previously described. 52, 53 Briefly, the ALIVE study comprises a cohort of IDUs in Baltimore who were prospectively followed up to study the natural history and risk factors of HIV/AIDS. 54 At each study visit, participants completed a detailed intervieweradministered questionnaire (IAQ) that collected information on demographics; personal health; sexual practices; and injection behaviors, including sharing of syringes and other paraphernalia (ie, cookers, cotton).
The Baltimore NEP was authorized by state legislation on August 12, 1994 and was initiated with the funding from the Baltimore City Health Department. During the study period, the NEP provided one of the only legal sources of sterile needles in Maryland. The program was operated through mobile vans and the pharmacy-based exchange sites. At initiation, trained staff conducted a brief 21-item registration survey. At baseline, participants were provided with 2 sterile syringes, cookers, sterile cotton, condoms, and HIV information brochures, and in their subsequent visits, they exchanged the used syringe for a sterile syringe in unlimited numbers on a 1:1 basis. On request, HIV testing with pre-and post-test counseling was available, along with tuberculosis skin testing and referrals to subsidized drug treatment.
Syringe Samples
Bar-coded syringes were dispensed between September 1994 and February 1997, whereby 746,029 syringes were exchanged by more than 5369 IDUs, and 197,216 of these were returned. All bar-coded syringes were nonnominally linked to each subject's unique identifier, enabling the identification of the individual(s) who acquired or returned any particular syringe from the Baltimore NEP, and also linked to the ALIVE study cohort, although preserving confidentiality. Between January 1995 and February 1996, a random number of 13,399 syringes exchanged by 893 IDUs were retained and rinsed with washing buffer, and their residues were stored at 270°C, as described more fully elsewhere in this report. In the present study, only the syringes with ALIVE study questionnaire data on the exchanger corresponding to the 6-month period of the visit to the Baltimore NEP were used. We excluded 4 individuals who exchanged more than 30 syringes per visit, because previous studies have shown that high-volume exchangers are those who sell syringes to others. 55 In this study, we examined a total of 2512 syringes exchanged by 315 ALIVE study participants during 728 NEP person-visits (Fig. 1) .
Syringe Exchanger Type
Barcode data linking individuals to each syringe returned per visit were used to create a matrix characterizing the type of syringe exchanger. During each visit, some IDUs returned only the syringes that they acquired (''primary'' syringes), others exchanged only the syringes that were acquired by others (''secondary'' syringes), and some exchanged primary and secondary syringes.
Laboratory Methods
Three STRs [W (D1S71752), X (D4S18742), and Z (D2S17842)] were used as biomarkers for validating selfreports of syringe sharing. The characteristics of the STRs (heterozygosity [H] , an extent of allelic polymorphism; the probability of mixture discrimination [P MD ], an estimate of the chance of detecting a third allele in a biologically mixed sample of the STRs (Table 1) ; and validity [sensitivity and specificity]) have been described previously. 41, 56 A stepwise laboratory procedure, including syringe washing, DNA extraction, polymerase chain reaction (PCR) amplification reaction with STRs, and fragment separation and sizing, was performed to differentiate between single person use (SPU) or MPU of syringes as previously described. 41 Briefly, washing buffer consisted of 10 mM of Tris hydrochloric acid (HCl), pH 8.3, 50 mM of potassium chloride (KCl), 2.5 mM of magnesium chloride (MgCl 2 ), Tween 20, and NP40. Fifty microliters of the buffer was used to dissolve the residues in the syringes thoroughly. DNA was extracted using a 96-format DNAamp blood kit (Qiagen, Hilden, Germany). A PCR assay was carried out separately for each STR genetic marker using the primers and conditions previously reported. 56 PCR fragments were separated by size using capillary electrophoresis. Because the fluorescent PCR products have upper detection thresholds in the Applied Biosystems 3100 genetic analyzer system, we used the Genescan and Genotyper programs (Applied Biosystems, Foster City, CA) to limit the peak heights of alleles to a maximum of 8000 relative fluorescent units (rfu) and reran the sample at lower concentrations (1/10 and 1/100) searching for suitable signal intensities. Two laboratory personnel visually inspected each electropherogram plot for all peak heights ,1000 rfu and determined the minimum threshold height to be the sum of the 2 highest STR alleles [500 rfu for W (D1S71752) and Z (D2S17842) and 850 rfu for X (D4S18742)] based on data quality.
Mixture Determination Algorithm
The quantitative algorithm based on STR peak height for determining true alleles versus the artifactual products or typical stutter has been described previously. 56 Briefly, the algorithm accounted for all possible stutters resulting from all the STR peaks and created a matrix of the expected stutter reference height at each allelic position. A true allele was differentiated if the observed peak at any allelic position was greater than the expected reference. Other misclassifications resulting from sensitive biomaterial amplification detection have been previously described, and our stringent algorithm for allele calling aims to maximize specificity in our analyses. 41, 56 Application of the algorithm in laboratory simulated samples yielded sensitivities of 77.5%, 82.7%, and 58% while maintaining the high specificities of 100%, 97.4%, and 100% for the W, X, and Z STRs individually as well as a collective sensitivity of 91.4% and a collective specificity of 97.4%. 56 Multiperson Use, Single Person Use, and No Detectable Genomic DNA Based on the genomic DNA contents, syringes were categorized as MPU, SPU, or ''no detectable genomic DNA'' (NDGD) as follows. The presence of 3 or more alleles was used to categorize syringes as MPU, and the presence of 1 or 2 alleles was used to categorize syringes as SPU. Thus, if any single STR resulted in evidence of MPU, the syringe was considered to be shared by at least 2 individuals. Conversely, if 2 or more STRs independently indicated SPU (or had missing data on the third STR), the syringe was considered to have been used by only 1 individual. NDGD indicated that the syringe had never been used (which is unlikely) or had been sterilized and washed properly before being returned to the NEP, leaving no traceable biologic materials (we are able to detect as little as 0.1 ng of DNA and mixtures with ratios as low as 95: 5 41 ). SPU syringes combined with NDGD in all STRs were grouped as non-MPU ''safe'' syringes in the analyses. These categorizations were used considering that from the public health perspective, non-MPU syringes indicate that the syringes were safely used, whereas MPU syringes indicate that the syringes were not safely used and could therefore transmit blood-borne pathogens.
Statistical Analysis
Each syringe was analyzed first to determine the genomic content as described in the Methods section. Syringes exchanged at each NEP person-visit by the participants were then used as the unit of analysis to estimate the proportion of MPU syringes returned to the program by each individual. The Cochran-Armitage trend test was performed to examine the trend in the proportion of MPU syringes as circulation time increased (ie, 1-3, 4-10, 11-20, 21-40, and more than 40 days). MPU syringes were also examined by the syringe exchanger type.
Further, among the primary exchangers, the level of MPU of syringes was examined to assess the associations with their demographic characteristics (age, gender, race, and HIV status) and self-reported injecting behaviors (lending syringes, borrowing syringes, sharing syringes, sharing cookers, sharing cotton, and attending shooting galleries). We used selfreported data from the ALIVE study visit that was closest in time to the Baltimore NEP visit when the syringe(s) were exchanged. The analysis was performed first with MPU versus SPU syringes only and then with MPU versus non-MPU syringes to assess safe versus ''unsafe'' use of syringes.
Using these demographic and self-reported variables, we identified predictors of needle sharing using a logistic regression model, with the response variable being the binomial proportion of MPU syringes for each NEP personvisit. The analysis was performed with logit link in SAS FIGURE 1. Study design and results of assessing syringe sharing. Genetic biomarker analyses of 3 STRs was performed on an overlapping set of 2512 syringes from 315 individuals for comparison to ALIVE study self-reports on risk behaviors. Syringes with 1 or 2 alleles observed in at least 2 loci examined were classified as SPU syringes, and those with 3 or more alleles at any loci were classified as MPU syringes.
(version 9.0) using the Proc Genmod function. Generalized estimating equations (GEEs) 57 were used to account for correlation between multiple visits for the same individuals using an exchangeable correlation structure. 58 Models also included an adjustment for the length of follow-up in the ALIVE study, because individuals who had been enrolled for a longer time were expected to be more prone to socially desirable responding. Variables that were significant at the 10% level in univariate analyses were also included in the multivariate analyses. All plausible 2-way interactions were explored. In each analysis, events that were missing relevant information because of nonresponse were excluded.
RESULTS
Individuals who acquired the syringes (n = 211) were not significantly different from those who returned them (n = 176) in terms of age (34.9 vs. 34. Residues obtained from 1234 syringes (56% of the syringes tested) were found to have evidence of MPU, 314 (14%) had evidence of SPU, and 658 (30%) had NDGD (Table  2) . Overall, significant increases in proportions of MPU syringes were observed the longer that syringes had been in circulation ( Fig. 2 ; trend test, P = 0.019). Syringes with the shortest circulation times (1-3 days) were shared less frequently than those circulating for longer periods (48% vs. 71%, x 2 = 114.26, 1 degree of freedom; P , 0.001). The prevalence of MPU was approximately 80% overall when only SPU and MPU syringes were used for the analyses (excluding those without detectable DNA). Given such high prevalence, none of the variables (syringe type, demographics, or self-reported risk behaviors) were associated with exchanging MPU syringes (analysis not shown). Further examination with exchanging unsafe syringes (ie, those indicating MPU) compared with safe syringes (ie, those indicating SPU or NDGD) led to a number of significant associations. Compared with individuals exchanging only primary syringes, return of MPU syringes versus return of SPU syringes was more likely for those exchanging primary and secondary syringes (64% Interestingly, the HIV serostatus of the subjects who acquired and returned syringes was not associated with MPU of syringes. To explore syringe use behaviors among high-risk and low-risk individuals, we also examined the secondary syringes exchanged by HIV-concordant (both individuals acquiring and returning the syringes were HIV-seropositive) and HIV-discordant pairs (where only 1 individual was HIV-seropositive), but no significant differences were observed (analysis not shown). Likewise, there was no difference in DNA detection between syringes exchanged by individuals who reported that they bleached syringes versus those who did not (analysis not shown).
DISCUSSION
The use of genetic biomarkers in conducting genomic analysis of syringe residues provides a promising methodology for differentiating MPU versus SPU of syringes. A unique feature of our study was the ability to link the syringes to the individuals who acquired or returned them at an NEP and to the self-reported behaviors from an ongoing cohort study. The present study was conducted with syringes from the Baltimore NEP in 1995 through 1996, and thus may not reflect the extent of MPU of syringes among current NEP attendees. It lays 56 †MPU $3 STR alleles. ‡SPU #2 STR alleles. § NDGD when no amplified PCR product was detected. All our positive control samples were amplified, and the alleles were correctly matched. None of our blank samples were amplified by PCR. Because the amount of DNA was not easy to titrate, a standard 10 mL of DNA from the extraction solution was used for PCR amplification in a total volume of 15 mL. The STR genetic markers examined have been previously described in detail relative to PCR conditions and amplification primers. 56 ''Unsafe''syringes included MPU syringes only and the ''safe''syringes included the SPU and NDGD syringes. Because there is no genomic detected (with all 3 STRs), it is assumed that there are no biologic materials, including the infectious agents; thus, these syringes were not used previously and/or they were disinfected properly (ie, washed or bleached); 59 thus, reusing the syringe would be a safe practice from the infection transmission point. a foundation for applying genetic biomarkers to study behavioral characteristics such as needle sharing, however.
Using a genomic analysis of 3 STRs, more than half (56%) of the Baltimore NEP syringes we studied had evidence of MPU. The prevalence of MPU of syringes we observed is higher than that of previous reports during the same period but could be attributable to the enrollment of high-risk individuals in the Baltimore NEP. For example, at baseline in the ALIVE study, which predated the introduction of NEPs, HIV and HCV prevalences were 25% and 88%, respectively. 52 Based on our analysis, 30% of the syringes had no evidence of genomic DNA. These syringes had never been used before or had been washed thoroughly with syringe cleaners (eg, bleach, detergent, soap), or they were left in extreme conditions (eg, heat) before specimen collection, resulting in DNA degradation. Samples were stored frozen after phosphate-buffered saline washes were performed until they were thawed for DNA extraction. DNA from archived material, as in our case, has been routinely analyzed in forensic cases; thus, degradation attributable to syringe residue storage is unlikely, although unknown conditions affecting the syringes could have affected the genetic tests by degrading the DNA. We did not test for trace amounts of perchlorate in the syringe residues; however, admittance of bleach use made no difference in DNA detection. We do not know whether the index person bleached the syringe before reusing it, whether the last user bleached the syringe before returning it to the NEP, or if the syringe was cleaned in any way at all. Bleach disinfects and inactivates bacteria and viruses within a few minutes. The effectiveness of a bleach depends on several factors, however, including concentration and time of exposure. 59 Several studies have suggested that IDUs do not clean their syringes effectively with bleach. 60, 61 We did not find any difference in MPU of syringes between those who admitted bleaching and those who did not, but we adjusted for this in all our analyses. If human biologic materials could not be detected in the residues, we inferred that most infectious microbes and viruses could not have survived.
Other studies have also indicated that NEPs may attract individuals who inject more frequently and engage in high-risk activities such as sharing needles. 18, 62, 63 Nearly half of the participants in our study were already HIV-seropositive, and 96% were HCV-seropositive. The prevalence of HIV is much higher in our study samples than in IDUs attending the NEP (29.5%) or participating in the ALIVE study (32%) during this same period, 34, 53 suggesting their involvement in high-risk behaviors even before attending the NEP. The fact that needles continued to be a commodity in Baltimore after the NEP opened attests to the fact that there remained an inadequate number of syringes exchanged in the city to meet the demand. During the period when the syringes for the present study were collected, the Baltimore NEP operated a van 4 days per week for 2 hours daily each on the east and west sides of the city. Although the hours and locations have been expanded in subsequent years, more work is needed to target the high-risk individuals who are hard to reach.
In other cities, for example, Montreal, ,5% of the estimated syringe demand was being met during the escalating HIV incidence among IDUs. 64 In Vancouver, it was estimated that more than double the amount of syringes was required on an annual basis to provide a sterile syringe for every injection, despite the effort to distribute more than 2 million syringes per year since 1996. 65 Likewise, low syringe coverage in the late 1990s was the main reason attributed to an HIV outbreak in Kathmandu, Nepal. 66 The fact that a significant difference in MPU of syringes was observed among those that were circulating for 1 to 3 days compared with the longer period supports the idea that the turnover rate of exchanged syringes needs to be increased to reduce the likelihood of a syringe being shared. According to Kaplan and Heimer's theory 67 of syringe circulation, the longer the syringe is out, the more likely it is that it is contaminated with HIV infection. Thus, provision of adequate syringes decreases the turnaround time during which potentially contaminated syringes may infect others. We found that injecting less than once daily was associated with decreased MPU of syringes. Increased injection frequency has been associated with HIV seroconversion in several studies. 53, 68 We also found that primary exchangers were less likely to share syringes than those who returned syringes acquired by others. This is not surprising, because a previous study has indicated that exchanging one's own syringes was significantly associated with lower levels of receptive needle sharing, backloading, sharing other injection equipment, and lending used needles. 69 We assumed that the individuals used the syringes they exchanged, and this could be a major limitation of our study. Self-reports may not reflect the actual user's behaviors, which would affect the validation analyses.
Interestingly, 35% of our subjects indicated that they did not inject drugs in the past 6 months in their interview. We did not see any significant differences in MPU of syringes between those who self-reported not injecting in the past 6 months versus those who did. Their participation in the NEP suggests response errors in their interviews or that they were exchanging syringes for someone else, which is known to be quite common in Baltimore. 70 Although we excluded highvolume exchangers (4 individuals with more than 30 syringes per NEP visit), who are known to sell syringes, we did not confirm that the syringes we sampled were used by the exchangers themselves. To confirm that the person who acquired the syringe at the NEP actually used it, forensic typing and subsequent analyses could be conducted in the future to match the STR allelic pattern from stored blood of each cohort participant to the residue contents present in the syringes. Although this would minimize misclassification and strengthen the inferences that can be drawn from this analysis, caution is needed regarding the ethics of conducting DNA profiling studies. Although the practice of secondary syringe exchange may be beneficial in reaching out to more hidden IDUs who do not use an NEP, they may not be exposed to the ancillary services (eg, condoms, prevention education, treatment referrals) that the program provides.
Although, there was no absolute agreement between the self-reports and the extent of needle sharing, our data suggest that MPU of syringes is more common in those who report direct or indirect sharing. Unaccounted indirect sharing 9, 13, 17 could be another explanation of the high prevalence of MPU syringes despite the lower rate of self-reported injection risk behaviors in our study. In a study of IDUs in Denver, Koester et al 71 found that 72% reported indirect sharing in the last 30 days, which was twice the rate of direct needle sharing. IDUs in many cities remain unaware of indirect sharing behaviors as risk factors for the spread of blood-borne infections. 10, 71, 72 Another study 17 reported that only 7% of IDUs were aware that indirect sharing represented a risk of becoming infected with HIV. Vlahov et al 18 previously reported prevalence of backloading, sharing cookers, sharing cotton, and attending shooting galleries among Baltimore NEP attendees at baseline to be 11.7%, 60.5%, 45.8%, and 22.9%, respectively. In our study, one third of IDUs reported sharing cookers and one fifth reported sharing cotton, but we lacked data on other indirect sharing of syringes and injection paraphernalia such as backloading, frontloading, and sharing rinse water. In fact, we found that sharing cotton was an independent predictor of exchanging MPU syringes. Injectors draw up drug solutions into their syringes through the cotton, which is used to filter out particulate matter. In such cases, the syringe of the second user can be contaminated with the biologic material from the first user and/or from the cooker. Thus, even if subsequent individuals use a sterile syringe or rinse the used syringe thoroughly with water, reuse of cotton can contaminate the syringe. Contact with cotton is the last process during the preparation of the drug solution before injection; thus, any contamination of the syringes, cookers, or water can also contaminate the cotton. Sharing cotton has been identified as an independent risk factor for HCV infection in several studies. 15, 16, 73 In contrast, forms of direct sharing other than lending syringes were not associated with MPU of syringes. IDUs may less readily engage in some forms of direct sharing, especially borrowing syringes from others (often referred to as receptive syringe sharing), but may feel comfortable admitting behaviors that are less socially unacceptable, such as lending to others (distributive syringe sharing) or indirect sharing. Also, in cases in which multiple persons engage in needle sharing, the order of syringe use is important, especially if the distributive user is infected with HIV and the receptive user is not. Although at an individual level, syringe use between seroconcordant individuals may not reflect as much risk as between serodiscordant individuals, sharing syringes generally remains a major risk factor for transmission of infectious disease at the population level.
In our study, some cohort participants were recruited as early as 1988, which is much earlier than our study period, and might have developed a close rapport with the interviewers, making them prone to socially desirable responding. We adjusted for follow-up time in our analysis to minimize the potential for this bias, however. Also, at semiannual study visits, participants are provided with risk reduction counseling, which may potentiate the tendency for underreporting risk behaviors. In addition, generalization of self-reported behaviors over a 6-month period may have confounded our results, because behaviors like needle sharing change over time. Nevertheless, given our study design, there were only a few syringe samples from each person over a relatively short follow-up period; thus, we did not have sufficient power to evaluate the change in pattern of sharing over time.
Our study has directly measured sharing of syringes through the use of genetic biomarkers for the first time. Our novel approach has important implications for future studies evaluating NEP effectiveness, understanding patterns of direct and indirect needle sharing, and potentially extending the method to unobtrusive public health surveillance of discarded street syringes in communities. Additionally, detection of DNA, RNA, or antibodies of infectious viruses such as HIV, HCV, and HBV in syringe exudates, along with sharing information, would be valuable in exploring models of transmission routes and pattern of infectious diseases among IDUs at the individual and population levels. Although there are concerns about self-reports, retrieving discarded needles using previously described street sampling methods 74 and testing them using this novel molecular method could provide estimates over time on rates of needle sharing in communities as a public health alert.
